VirnetX Holding Corp (NYSE:VHC - Get Free Report) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $12.21 and traded as high as $17.49. VirnetX shares last traded at $16.80, with a volume of 2,505 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen upgraded VirnetX from a "sell" rating to a "hold" rating in a research note on Saturday, August 16th.
View Our Latest Stock Analysis on VHC
VirnetX Stock Up 1.8%
The company has a market capitalization of $71.75 million, a P/E ratio of -3.50 and a beta of 1.84. The business has a 50 day moving average of $15.87 and a 200 day moving average of $12.21.
VirnetX (NYSE:VHC - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The technology company reported ($0.99) earnings per share (EPS) for the quarter. The business had revenue of $0.05 million during the quarter.
Hedge Funds Weigh In On VirnetX
A hedge fund recently raised its stake in VirnetX stock. Csenge Advisory Group lifted its holdings in VirnetX Holding Corp (NYSE:VHC - Free Report) by 11.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 24,002 shares of the technology company's stock after buying an additional 2,448 shares during the period. Csenge Advisory Group owned about 0.57% of VirnetX worth $177,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 10.37% of the company's stock.
VirnetX Company Profile
(
Get Free Report)
VirnetX Holding Corporation, through its subsidiary VirnetX, Inc, operates as an Internet security software and technology company primarily in the United States. The company develops software and technology solutions, including secure domain name registry and GABRIEL Connection Technology that are designed to secure communications over the Internet using zero trust network access.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider VirnetX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VirnetX wasn't on the list.
While VirnetX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.